1. Home
  2. ADM vs RVMD Comparison

ADM vs RVMD Comparison

Compare ADM & RVMD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Archer-Daniels-Midland Company

ADM

Archer-Daniels-Midland Company

HOLD

Current Price

$81.05

Market Cap

37.4B

ML Signal

HOLD

Logo Revolution Medicines Inc.

RVMD

Revolution Medicines Inc.

HOLD

Current Price

$145.82

Market Cap

30.1B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
ADM
RVMD
Founded
1902
2014
Country
United States
United States
Employees
N/A
883
Industry
Packaged Foods
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Consumer Staples
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
37.4B
30.1B
IPO Year
2008
N/A

Fundamental Metrics

Financial Performance
Metric
ADM
RVMD
Price
$81.05
$145.82
Analyst Decision
Hold
Strong Buy
Analyst Count
6
19
Target Price
$64.00
$140.84
AVG Volume (30 Days)
3.7M
2.5M
Earning Date
05-05-2026
05-06-2026
Dividend Yield
2.80%
N/A
EPS Growth
N/A
N/A
EPS
0.62
N/A
Revenue
$80,269,000,000.00
N/A
Revenue This Year
$4.80
N/A
Revenue Next Year
$2.77
$533.02
P/E Ratio
$129.37
N/A
Revenue Growth
N/A
N/A
52 Week Low
$46.81
$34.00
52 Week High
$83.10
$155.70

Technical Indicators

Market Signals
Indicator
ADM
RVMD
Relative Strength Index (RSI) 66.38 57.13
Support Level $57.63 $93.39
Resistance Level N/A $152.38
Average True Range (ATR) 2.53 5.86
MACD 0.46 -1.40
Stochastic Oscillator 79.86 46.61

Price Performance

Historical Comparison
ADM
RVMD

About ADM Archer-Daniels-Midland Company

Archer-Daniels-Midland is a major processor of oilseeds, corn, wheat, and other agricultural commodities. The company is also one of the largest grain merchandisers through its extensive network of logistical assets to store and transport crops around the globe. ADM also runs a nutrition business that focuses on both human and animal ingredients and is a large producer of corn-based sweeteners, starches, and ethanol.

About RVMD Revolution Medicines Inc.

Revolution Medicines Inc is a clinical-stage precision oncology company developing novel targeted therapies for RAS-addicted cancers. The Company possesses structure-based drug discovery capabilities built upon chemical biology and cancer pharmacology know-how and proprietary technologies that enable the creation of small molecules tailored to unconventional binding sites. Its research and development pipeline comprises inhibitors that bind directly to RAS variants (RAS(ON) Inhibitors), designed to be used as monotherapy, in combination with other RAS(ON) Inhibitors and/or other therapeutic agents.

Share on Social Networks: